FEED offering history
Every offering-related filing in ENvue Medical, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 545 filings back to May 5, 2005.
| Date | Filing | What it means | |
|---|---|---|---|
| Aug 10, 2026 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 28, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 28, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 18, 2026 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Dec 18, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 18, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 10, 2025 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Oct 6, 2025 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Sep 17, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 15, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jul 22, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 16, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| May 14, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| May 14, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 12, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Apr 29, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Apr 22, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 14, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 14, 2025 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Jan 7, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 21, 2023 | RW → | WITHDRAWN | Registration withdrawn |
| Sep 21, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Sep 21, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 12, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Sep 1, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 11, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 7, 2023 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Aug 1, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jul 17, 2023 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Dec 1, 2022 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Nov 30, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 22, 2021 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 16, 2020 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 15, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 10, 2020 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Dec 7, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 24, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 24, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 23, 2020 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Sep 23, 2020 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
FEED offering FAQ
When did FEED last execute an offering?
Per SEC filings, ENvue Medical, Inc.'s most recent priced offering document is a 424B5 filed 2025-09-17. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did FEED last announce or register an offering?
The most recent registration is a S-3 filed 2026-08-10. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.